Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't ...

Cancerguard detects multiple cancers early by identifying specific DNA and protein markers in a blood sample. The test is ...

Tumor markers for small cell lung cancer (SCLC) are measurable using blood tests, such as neuron-specific enolase (NSE). They can support the identification and management of cancer. Doctors use a ...

Pancreatic cancer is cancer that starts in the pancreas. The pancreas makes enzymes and hormones vital for promoting digestion and regulating blood sugar. Specific biomarkers, called tumor markers, ...

(San Diego, CA) August 21, 2009 – GenWay Clinical Laboratory, a US-based diagnostic company with CLIA certification, has validated a general tumor marker test in their laboratory and now offers this ...

TEXAS – A new wave of blood tests is changing how doctors detect cancer. These tests can find signs of cancer early, ...

Testing lung cancer patients for tumor markers would enable doctors to choose which drug the patient is most likely to respond to, improving the chances for successful treatment, according to results ...

A tumor marker for pancreatic cancer helps healthcare professionals detect, diagnose, or treat it. However, a person can have high tumor marker levels without having cancer. Tumor markers are ...

Over a 1-year period, the mean number of any individual test per patient was seven tests, and the maximum number was 35 tests; the mean number of total tests per patient was 12 tests, and the maximum ...

SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive, accurate tests for the detection of early-stage cancer ...